ArticleJournal of oncology2021

LMTK2 as Potential Biomarker for Stratification between Clinically Insignificant and Clinically Significant Prostate Cancer.

Alvydas Vezelis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.